Clinical Trial Update: A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) [Phase 2]

View source ↗

Summary

Phase 2 REGENERATE-PD trial evaluating AAV2-GDNF in adults with moderate Parkinson disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AAV2-GDNF

Snippet

Sponsor: AskBio Inc | Conditions: Parkinson Disease | Phase 2 | Status: RECRUITING